These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


411 related items for PubMed ID: 25175317

  • 1. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis.
    Treglia G, Sadeghi R, Giovanella L, Cafarotti S, Filosso P, Lococo F.
    Lung Cancer; 2014 Oct; 86(1):5-13. PubMed ID: 25175317
    [Abstract] [Full Text] [Related]

  • 2. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.
    Lococo F, Cesario A, Okami J, Cardillo G, Cavuto S, Tokunaga T, Apolone G, Margaritora S, Granone P.
    Lung Cancer; 2013 Nov; 82(2):245-51. PubMed ID: 23992878
    [Abstract] [Full Text] [Related]

  • 3. Value of 18F-FDG PET/computed tomography in predicting the simplified WHO grade of malignancy in thymic epithelial tumors.
    Zhao J, Wang H, Li Q.
    Nucl Med Commun; 2020 Apr; 41(4):405-410. PubMed ID: 32032191
    [Abstract] [Full Text] [Related]

  • 4. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H, Kondo K, Sadohara Y, Otsuka H, Morimoto M, Kajiura K, Nakagawa Y, Yoshida M, Kawakami Y, Takizawa H, Kenzaki K, Sakiyama S, Bando Y, Tangoku A.
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [Abstract] [Full Text] [Related]

  • 5. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
    Fukumoto K, Taniguchi T, Ishikawa Y, Kawaguchi K, Fukui T, Kato K, Matsuo K, Yokoi K.
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234
    [Abstract] [Full Text] [Related]

  • 6. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.
    Seki N, Sakamoto S, Karube Y, Oyaizu T, Ishihama H, Chida M.
    Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867
    [Abstract] [Full Text] [Related]

  • 7. Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters.
    Park SY, Cho A, Bae MK, Lee CY, Kim DJ, Chung KY.
    Clin Nucl Med; 2016 Jan; 41(1):15-20. PubMed ID: 26545017
    [Abstract] [Full Text] [Related]

  • 8. The efficacy of 18F-FDG-PET-based radiomic and deep-learning features using a machine-learning approach to predict the pathological risk subtypes of thymic epithelial tumors.
    Nakajo M, Takeda A, Katsuki A, Jinguji M, Ohmura K, Tani A, Sato M, Yoshiura T.
    Br J Radiol; 2022 Jun 01; 95(1134):20211050. PubMed ID: 35312337
    [Abstract] [Full Text] [Related]

  • 9. Fluorodeoxyglucose Positron Emission Tomography Can Provide Useful Information for Differentiating Thymic Epithelial Tumors.
    Tomita M, Ayabe T, Tsuchiya K, Nakamura K.
    Thorac Cardiovasc Surg; 2018 Jun 01; 66(4):345-349. PubMed ID: 28728209
    [Abstract] [Full Text] [Related]

  • 10. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT.
    Lee HS, Oh JS, Park YS, Jang SJ, Choi IS, Ryu JS.
    Ann Nucl Med; 2016 May 01; 30(4):309-19. PubMed ID: 26868139
    [Abstract] [Full Text] [Related]

  • 11. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.
    Endo M, Nakagawa K, Ohde Y, Okumura T, Kondo H, Igawa S, Nakamura Y, Tsuya A, Murakami H, Takahashi T, Yamamoto N, Ito I, Kameya T.
    Lung Cancer; 2008 Sep 01; 61(3):350-5. PubMed ID: 18304691
    [Abstract] [Full Text] [Related]

  • 12. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
    De Luca S, Fonti R, Palmieri G, Federico P, Del Prete G, Pacelli R, Pace L, De Placido S, Salvatore M, Del Vecchio S.
    Clin Nucl Med; 2013 May 01; 38(5):354-8. PubMed ID: 23486323
    [Abstract] [Full Text] [Related]

  • 13. Thymic epithelial tumors: Can fluorodeoxyglucose positron emission tomography help in predicting histologic type and stage?
    Purandare NC, Pramesh CS, Karimundackal G, Jiwnani S, Agrawal A, Shah S, Agarwal JP, Prabhash K, Noronha V, Joshi A, Kumar R, Rangarajan V.
    Indian J Cancer; 2016 May 01; 53(2):270-273. PubMed ID: 28071625
    [Abstract] [Full Text] [Related]

  • 14. The Role of [18F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage.
    Civan C, Ozkan ZG, Ozkan B, Isik EG, Erdogdu E, Has Simsek D, Duman S, Sanli Y, Kara M, Kuyumcu S, Toker A.
    Cancer Biother Radiopharm; 2024 Jun 01; 39(5):373-380. PubMed ID: 38484307
    [Abstract] [Full Text] [Related]

  • 15. Is a positron emission tomography-computed tomography scan useful in the staging of thymic epithelial neoplasms?
    Viti A, Terzi A, Bianchi A, Bertolaccini L.
    Interact Cardiovasc Thorac Surg; 2014 Jul 01; 19(1):129-34. PubMed ID: 24648467
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of [18F]fluoro-2-deoxy-D-glucose positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors.
    Igai H, Matsuura N, Tarumi S, Chang SS, Misaki N, Go T, Ishikawa S, Yokomise H.
    Eur J Cardiothorac Surg; 2011 Jul 01; 40(1):143-5. PubMed ID: 20951602
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial tumors.
    Liu Y.
    Nucl Med Commun; 2011 Jul 01; 32(7):554-62. PubMed ID: 21403583
    [Abstract] [Full Text] [Related]

  • 19. 18-Fluorine fluorodeoxyglucose positron emission tomography in the pretreatment evaluation of thymic epithelial neoplasms: a metabolic biopsy confirmed by Ki-67 expression.
    Viti A, Bertolaccini L, Cavallo A, Fortunato M, Bianchi A, Terzi A.
    Eur J Cardiothorac Surg; 2014 Sep 01; 46(3):369-74; discussion 374. PubMed ID: 24585679
    [Abstract] [Full Text] [Related]

  • 20. Superiority of [68Ga]Ga-DOTA-FAPI-04 PET/CT to [18F]FDG PET/CT in the evaluation of thymic epithelial tumours.
    Shen X, Zhou X, Yao Y, Meng X, Song Y, Yang Z, Li N.
    Eur J Nucl Med Mol Imaging; 2023 Sep 01; 50(11):3414-3424. PubMed ID: 37316675
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.